These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3020859)

  • 1. Role of VSV G antigen in the development of experimental spongiform encephalopathy in mice.
    Robain O; Chany-Fournier F; Cerutti I; Màzlo M; Chany C
    Acta Neuropathol; 1986; 70(3-4):220-6. PubMed ID: 3020859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurovirulence mutant of vesicular stomatitis virus with an altered target cell tropism in vivo.
    Preble OT; Costello LE; Huang DD; Barmada MA
    Infect Immun; 1980 Aug; 29(2):744-57. PubMed ID: 6163714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine central nervous system infection by a viral temperature-sensitive mutant: a subacute disease leading to demyelination.
    Dal Canto MC; Rabinowitz SG
    Am J Pathol; 1981 Mar; 102(3):412-26. PubMed ID: 6259945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of vesicular stomatitis virus (VSV) RNA in the central nervous system of infected mice by in situ hybridization.
    Fournier JG; Robain O; Cerutti I; Tardivel I; Chany-Fournier F; Chany C
    Acta Neuropathol; 1988; 75(6):554-6. PubMed ID: 2837039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of spongiform encephalopathy in retroviral infected mice.
    Nagra RM; Burrola PG; Wiley CA
    Lab Invest; 1992 Mar; 66(3):292-302. PubMed ID: 1311397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.
    Zinkernagel RM; Althage A; Holland J
    J Immunol; 1978 Aug; 121(2):744-8. PubMed ID: 210232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural-immunohistochemical evidence for a maturation defect of temperature-sensitive G31 vesicular stomatitis virus in murine spinal cord neurons.
    Dal Canto MC; Rabinowitz SG; Johnson TC; Hughes JV
    Infect Immun; 1979 Apr; 24(1):276-81. PubMed ID: 222680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative neurovirulence of selected vesicular stomatitis virus temperature-sensitive mutants of complementation groups II and III.
    Rabinowitz SG; Huprikar J; Dal Canto MC
    Infect Immun; 1981 Jul; 33(1):120-5. PubMed ID: 6266962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.
    Schnell MJ; Buonocore L; Kretzschmar E; Johnson E; Rose JK
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11359-65. PubMed ID: 8876140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of formation of pseudotypes between vesicular stomatitis virus and murine leukemia virus.
    Witte ON; Baltimore D
    Cell; 1977 Jul; 11(3):505-11. PubMed ID: 195740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible block in intracellular transport and budding of mutant vesicular stomatitis virus glycoproteins.
    Lodish HF; Kong N
    Virology; 1983 Mar; 125(2):335-48. PubMed ID: 6301145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementation of a vesicular stomatitis virus glycoprotein G mutant with wild-type protein expressed from either a bovine papilloma virus or a vaccinia virus vector system.
    Lefkowitz EJ; Pattnaik AK; Ball LA
    Virology; 1990 Oct; 178(2):373-83. PubMed ID: 2171187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.
    Foley HD; McGettigan JP; Siler CA; Dietzschold B; Schnell MJ
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14680-5. PubMed ID: 11114165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shedding of vesicular stomatitis virus soluble glycoprotein by removal of carboxy-terminal peptide.
    Irving RA; Ghosh HP
    J Virol; 1982 Apr; 42(1):322-5. PubMed ID: 6283151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesicular stomatitis virus infection and neuropathogenesis in the murine model are associated with apoptosis.
    Sur JH; Allende R; Doster AR
    Vet Pathol; 2003 Sep; 40(5):512-20. PubMed ID: 12949408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute infection with temperature-sensitive vesicular stomatitis virus mutant G41 in the central nervous system of mice. II. Immunofluorescent, morphologic, and immunologic studies.
    Dal Canto MC; Rabinowitz SG; Johnson TC
    J Infect Dis; 1979 Jan; 139(1):36-51. PubMed ID: 220329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle.
    Mackett M; Yilma T; Rose JK; Moss B
    Science; 1985 Jan; 227(4685):433-5. PubMed ID: 2981435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein.
    Whitt MA; Buonocore L; Prehaud C; Rose JK
    Virology; 1991 Dec; 185(2):681-8. PubMed ID: 1660200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of spongiform neurodegenerative disease induced by a highly virulent murine retrovirus.
    Czub S; Lynch WP; Czub M; Portis JL
    Lab Invest; 1994 May; 70(5):711-23. PubMed ID: 8196367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.